Middle East and Africa Gene Expression Market Report and Forecast 2024-2032

Middle East and Africa Gene Expression Market Report and Forecast 2024-2032

Middle East and Africa Gene Expression Market Report and Forecast 2024-2032

Middle East and Africa Gene Expression Market Size

The global gene expression market was valued at USD 13.3 billion in 2023, with the Middle East and Africa holding a significant market share. The market is driven by the increased government initiatives and funding in genomic research. It is expected to grow at a CAGR of 10.42% during the forecast period of 2024-2032, with the values likely to attain USD 32.4 billion by 2032.

Middle East and Africa Gene Expression Market Outlook

• Recent data reveals that around 22,000 people in Saudi Arabia die from the four main non-communicable diseases every year, accounting for 35% of all deaths in the Kingdom of Saudi Arabia. This rising disease burden is likely to augment the demand for gene expression tools and services.
• One of the major Middle East and Africa gene expression market trends is the increased government initiatives and funding to stimulate research and innovation in the genomics sector. In January 2024 , the Saudi Arabian government launched the National Biotech Strategy, intending to give the highest priority to genomics, among 4 other cutting-edge areas.
• The market share is also impacted by the rising healthcare expenditure, which often leads to increased funding for genomics and gene expression studies. For instance, under Vision 2030 , the Saudi Arabian government is planning to invest more than USD 65 billion towards the development of the country’s healthcare infrastructure and health services.

Middle East and Africa Gene Expression Market Analysis

The market involves the analysis, manipulation, or measurement of gene expression patterns within cells or tissues. It comprises a range of products, technologies, and services aimed at studying gene expression. Several pharmaceutical and biotechnology companies are increasingly utilizing gene expression analysis in biomarker identification and drug discovery to develop novel drugs. Moreover, the growing demand for personalized medicine and targeted therapies is expected to drive the Middle East and Africa gene expression market growth in the forecast period.

The market Is also influenced by the increasing burden of non-communicable diseases in the region, which takes a significant toll on mortality and morbidity. Recent data reveals that around 22,000 people in Saudi Arabia die from the four main non-communicable diseases (cardiovascular diseases, cancer, diabetes , and chronic respiratory diseases) every year, accounting for 35% of all deaths in the Kingdom of Saudi Arabia. Additionally, more than 1 in 4 people are suffering from one of the 4 main non-communicable diseases, indicating the need for effective treatment options. Gene expression analysis is integral to understanding disease progression, prognosis, and treatment response as well as plays a key role in drug discovery and development. Consequently, the rising disease burden is likely to augment the Middle East and Africa gene expression market demand.

One of the major market trends is the increased government initiatives and fundings to stimulate research and innovation in the genomics sector. In January 2024 , the Saudi Arabian government launched the National Biotech Strategy as part of the project Vision 2030, with the aim to make the Kingdom of Saudi Arabia a leading biotech hub in the Middle East and Africa by 2030 and a global biotech leader by 2040. The strategy plans to give the highest priority to genomics, among 4 other cutting-edge areas, to fuel genomic research and foster advancement in precision and individualized medicine. Such rigorous government support is anticipated to boost the Middle East and Africa gene expression market share.

The market is also impacted by the rising healthcare expenditure, which often leads to increased funding for biomedical research, including genomics and gene expression studies. For instance, under Vision 2030 , the Saudi Arabian government is planning to invest more than USD 65 billion towards the development of the country’s healthcare infrastructure and health services. Such substantial investments are poised to elevate the market value in the coming years. Further, the rising foreign investment in the region by the leading market players is expected to accelerate the market growth.

Middle East and Africa Gene Expression Market Segmentation  

The report offers a detailed analysis of the market based on the following segments:

Market Breakup by Technology

• Polymerase Chain Reaction
• Next Generation Sequencing
• Microarrays
• Northern Blotting
• Others

Market Breakup by Product

Consumables and Reagents

Instruments

Services

Market Breakup by End User

Drug Discovery and Development Centres

Diagnostic Laboratories

Academic Research Centers

Others

Market Breakup by Country

• Saudi Arabia
• United Arab Emirates
• Nigeria
• South Africa
• Others

Leading Players in the Middle East and Africa Gene Expression Market

The key features of the market report include patent analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:

• Thermo Fisher Scientific Inc.
• Bio-Rad Laboratories
• Illumina, Inc.
• QIAGEN
• F. Hoffmann-La Roche Ltd.
• REVVITY
• PacBio
• Agilent Technologies, Inc.
• Sysmex Corporation
• BGI
• Eurofins Scientific SE

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

FAQs

• What is the Middle East and Africa gene expression market forecast outlook for 2024-2032?

The Middle East and Africa gene expression market is expected to be driven by the rising demand for the global market, which is anticipated to grow at a CAGR of 10.42% during the forecast period of 2024-2032 and is likely to reach a market value of USD 32.4 billion by 2032.

• What are the major factors aiding the Middle East and Africa gene expression market demand?

The growing demand for personalized medicine and targeted therapies is fuelling the demand for the market.

• What are the major Middle East and Africa gene expression market trends?

One of the significant trends in the market is the increased government initiatives and funding to stimulate research and innovation in the genomics sector. In January 2024, the Saudi Arabian government launched the National Biotech Strategy, intending to give the highest priority to genomics, among 4 other cutting-edge areas.

• What is the market segmentation based on technology?

Based on the technology, the market is segmented into polymerase chain reaction, next-generation sequencing, microarrays, and northern blotting, among others.

• What is the market breakup by product type?

By product type, the market is divided into instruments, reagents, consumables, and services.

• What are the major end users of the gene expression market?

End users of the market are drug discovery and development centers, diagnostic laboratories, and academic research centers, among others.

• What is the market segmentation by countries?

The market segmentation by countries includes Saudi Arabia, the United Arab Emirates, Nigeria, and South Africa, among others.

• Who are the key players involved in the Middle East and Africa gene expression market?

The key players in the market are Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Illumina, Inc., QIAGEN, F. Hoffmann-La Roche Ltd., REVVITY, PacBio, Agilent Technologies, Inc., Sysmex Corporation, BGI, and Eurofins Scientific SE.

Meta description

The Middle East and Africa gene expression market is poised for growth, driven by the expansion of the global market, which was valued at USD 13.3 billion in 2023 and is projected to grow at a CAGR of 10.42% during the forecast period of 2024-2032.

*Please Note:* The report will take 7 business days to complete, after order confirmation.